László Vécsei MD PhD DSc
László Vécsei MD PhD DSc
University of Szeged, Faculty of Medicine, Department of Neurology
Verifierad e-postadress pĺ med.u-szeged.hu
Citeras av
Citeras av
The epidemiology of multiple sclerosis in Europe
M Pugliatti, G Rosati, H Carton, T Riise, J Drulovic, L Vécsei, I Milanov
European journal of Neurology 13 (7), 700-722, 2006
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
K Sas, H Robotka, J Toldi, L Vécsei
Journal of the neurological sciences 257 (1-2), 221-239, 2007
Kynurenines in the CNS: recent advances and new questions
L Vécsei, L Szalárdy, F Fülöp, J Toldi
Nature reviews Drug discovery 12 (1), 64-82, 2013
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …
JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...
The Lancet Neurology 16 (12), 976-986, 2017
EFNS guideline on mild traumatic brain injury: report of an EFNS task force
PE Vos, L Battistin, G Birbamer, F Gerstenbrand, A Potapov, T Prevec, ...
European journal of neurology 9 (3), 207-219, 2002
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
The kynurenine system and immunoregulation
Y Mándi, L Vécsei
Journal of neural transmission 119, 197-209, 2012
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
Mild traumatic brain injury
PE Vos, Y Alekseenko, L Battistin, E Ehler, F Gerstenbrand, DF Muresanu, ...
European journal of neurology 19 (2), 191-198, 2012
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
B Tuka, Z Helyes, A Markovics, T Bagoly, J Szolcsányi, N Szabo, E Tóth, ...
Cephalalgia 33 (13), 1085-1095, 2013
Monoamine oxidase B inhibitors in Parkinson's disease
L Dezsi, L Vecsei
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017
Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection
K Sas, E Szabó, L Vécsei
Molecules 23 (1), 191, 2018
Role of kynurenines in the central and peripherial nervous systems
H Nemeth, J Toldi, L Vecsei
Current neurovascular research 2 (3), 249-260, 2005
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
The Lancet Neurology 17 (12), 1053-1060, 2018
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...
Muscle & nerve 60 (1), 14-24, 2019
Exploring the etiological links behind neurodegenerative diseases: Inflammatory cytokines and bioactive kynurenines
M Tanaka, J Toldi, L Vécsei
International Journal of Molecular Sciences 21 (7), 2431, 2020
Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway
M Tanaka, F Tóth, H Polyák, Á Szabó, Y Mándi, L Vécsei
Biomedicines 9 (7), 734, 2021
Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
A Pardutz, I Krizbai, S Multon, L Vecsei, J Schoenen
Neuroreport 11 (14), 3071-3075, 2000
Carotid stenosis and the cognitive function
LK Sztriha, D Nemeth, T Sefcsik, L Vecsei
Journal of the neurological sciences 283 (1-2), 36-40, 2009
Systemet kan inte utföra ĺtgärden just nu. Försök igen senare.
Artiklar 1–20